Ferric derisomaltose and Outcomes in the Recovery of Gynecologic oncology: ERAS (Enhanced Recovery After Surgery) (FORGE) – a protocol for a pilot randomised double-blinded parallel-group placebo-controlled study of the feasibility and efficacy of intravenous ferric derisomaltose to correct preoperative iron-deficiency anaemia in patients undergoing gynaecological oncology surgery

INTRODUCTION: Iron-deficiency anaemia is common in gynaecological oncology patients. Blood transfusions are immunosuppressive and carry immediate and long-term risks. Oral iron replacement remains the standard of care but requires prolonged treatment courses associated with gastrointestinal side eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisch, Steven P, Woo, Lawrence, Ljungqvist, Olle, Nelson, Gregg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649621/
https://www.ncbi.nlm.nih.gov/pubmed/37945297
http://dx.doi.org/10.1136/bmjopen-2023-074649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649621/
https://www.ncbi.nlm.nih.gov/pubmed/37945297
http://dx.doi.org/10.1136/bmjopen-2023-074649

Ejemplares similares